Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences to Peer Perform from Outperform with a "fair value" range for the stock at $65-$85.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EW: